MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM)

Authors
Category Primary study
JournalNEURO-ONCOLOGY
Year 2023
This article has no abstract
Epistemonikos ID: 5a9849e1ba49f8a8482a93d936f8419b8c27e176
First added on: Feb 16, 2025